Activity Details

Free CME
1.0 AMA PRA Category 1 Credit
Released: December 14, 2017
Expires: December 14, 2018
1 hour to complete

Jointly Provided By


Target Audience

Gastroenterologists and gastroenterology nurse practitioners (NPs) and PAs

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  1. Differentiate between current, novel, and future IBD therapies based on their efficacy and safety data
  2. Devise an individualized and adaptable treatment plan for patients with IBD to maximize remission, avoid relapse, and minimize toxicity
  3. Assess disease progression and utilize drug monitoring strategies to optimize treatment of patients with IBD
  4. Employ a strong patient-provider collaborative approach to managing patients with IBD that includes patient education, engagement, and shared decision making

Activity Description

This unique Clinical Convergence® educational activity integrates healthcare provider and patient perspectives with clinical content that focuses on several aspects of inflammatory bowel disease (IBD) care, including personalized treatment decisions, patient and drug monitoring, and shared decision making.

Based on the proceedings from a live regional half-day symposium for healthcare providers and patients hosted by the Crohn’s & Colitis Foundation, RMEI Medical Education, LLC, and the University of Cincinnati, this activity features three IBD patient case vignettes, challenging interactive questions related to the cases, and audio interaction from the actual patients presented in the vignettes. It is designed to engage learners and offer real-time teaching moments illustrating the potential differences between clinician and patient perceptions of their care and to demonstrate effective care strategies, from the patient perspective.

A handout listing educational resources based on today’s topics of shared decision making, treatment, and monitoring, is available for download at the end of the activity.


Millie D. Long, MD, MPH
Associate Professor of Medicine
Division of Gastroenterology and Hepatology
Director, Gastroenterology and Hepatology Fellowship Program
University of North Carolina School of Medicine
Chapel Hill, NC

Dr. Long discloses the following relationships with commercial interests:
AbbVie Inc., Pfizer Inc., Takeda Pharmaceuticals USA, Inc., and TARGET PharmaSolutions (Consultant); Takeda Pharmaceuticals USA, Inc. (Research Support); and AbbVie Inc. and UCB (Speaker).

Meenakshi Bewtra, MD, MPH, PhD
Assistant Professor of Medicine, Division of Gastroenterology
Senior Scholar, Center for Clinical Epidemiology and Biostatistics
University of Pennsylvania School of Medicine
Philadelphia, PA

Dr. Bewtra discloses the following relationships with commercial interests:
Janssen Pharmaceuticals, Inc. (Consultant); GlaxoSmithKline and Takeda Pharmaceuticals USA, Inc. (Research Support); and AbbVie Inc. (Speaker).

Derek R. Patel, MD
Clinical Professor of Medicine
Associate Clinical Services Chief
Division of Gastroenterology
University of California, San Diego
San Diego, CA

Dr. Patel discloses the following relationships with commercial interests:
AbbVie Inc. (Consultant) and AbbVie Inc. (Speaker).

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Crohn’s & Colitis Foundation
Sudha Sarode, MSPH, has no relevant relationships to disclose.

RMEI Medical Education, LLC
Sherri Kramer, MD, has no relevant relationships to disclose.
Tania Dickson has no relevant relationships to disclose.
Jessica Hatch has no relevant relationships to disclose.

University of Cincinnati
Susan P. Tyler, MEd, CMP, CHCP, FACEHP, Director, has no relevant relationships to disclose.
Rick E. Ricer, MD, has no relevant relationships to disclose.
Deborah Cole, BS, has no relevant relationships to disclose.

Conflict of Interest Policy / Disclosure Statement

According to the disclosure policy of the University of Cincinnati, all faculty, planning committee members, and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interest related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity, and levels of evidence. Disclosure will be made at the time of activity.

In accordance with the ACCME Standards for Commercial Support, the speakers for this course have been asked to disclose to participants the existence of any financial interest and/or relationship(s) (eg, paid speaker, employee, paid consultant on a board, and/or committee for a commercial company) that would potentially affect the objectivity of his/her presentation or whose products or services may be mentioned during their presentation.

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati, the Crohn’s & Colitis Foundation, and RMEI Medical Education, LLC. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.

Designation of Credit

The University of Cincinnati designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Instructions for Receiving Credit

By completing the curriculum challenge (at the beginning and again at the end of the activity), the pre-test, reviewing the course content, and successfully completing the post-test and evaluation, physicians, nurse practitioners, and PAs are entitled to receive up to 1.0 AMA PRA Category 1 Credit™. A statement of credit will be available to print from your user history page.

Users must:
1. Read the learning objectives and faculty disclosures.
2. Participate in the activity.
3. Complete the activity evaluation.

Physicians, nurse practitioners, and PAs who successfully complete the post-test and evaluation will receive CME credit. You must score 75% or higher on the post-test to receive credit for this activity. All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.

Statement of Commercial Support

This activity is supported by independent educational grants from AbbVie Inc., Celgene Corporation, Salix Pharmaceuticals, and Takeda Pharmaceuticals USA, Inc.

Off-label Disclosure Statement

Faculty members are required to inform the audience when they are discussing off-label, unapproved uses of devices and drugs. Physicians should consult full prescribing information before using any product mentioned during this educational activity.

Disclaimer Statement

The opinions expressed during the enduring material activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati. The information is presented for the purpose of advancing the attendees’ professional development. Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Contact Information for Questions about the Activity

Accreditation Support:
Please contact the University of Cincinnati, Continuing Medical Education Department at or by calling 513-558-7277.

Technical Support:
For any technical issues or issues with your CME Certificate, please visit:

Course Viewing

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Start Activity

Select your specialty

You must select a specialty

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.